Men’s health clinic statistics

TRT clinic statistics for 2026, from prescribing trends to search demand

26 figures on testosterone use, retention, trial evidence, rules, costs and what men search, each read at its source in November 2026.

The TRT questions men ask AI engines, dated
Trusted by the world's fastest-growing brands

Patients and prescribing

Who uses testosterone, and how long new users keep going

One primary care prevalence study and one large insurer database, both dated. No newer national prescribing figure was found at a primary source.

FigureWhat it measuresSource
38.7%Men 45 or older seen in US primary care offices whose total testosterone measured below 300 ng/dL, of 2,162 in the HIM studyMulligan T. et al., “Prevalence of hypogonadism in males aged at least 45 years: the HIM study”, International Journal of Clinical Practice, July 2006
2.91%Commercially insured US men 40 or older using testosterone in 2011, more than three times the 0.81% of 2001Baillargeon J. et al., “Trends in androgen prescribing in the United States, 2001 to 2011”, JAMA Internal Medicine, August 12, 2013
3.77%Testosterone use among insured men 40 or older in the South in 2010; the West stood at 2.61%, the Midwest at 1.78% and the Northeast at 1.60%Baillargeon J. et al., “Trends in androgen prescribing in the United States, 2001 to 2011”, JAMA Internal Medicine, August 12, 2013
74.72%New testosterone users, 2001 to 2011, who had a testosterone level measured in the 12 months before their first prescriptionBaillargeon J. et al., “Trends in androgen prescribing in the United States, 2001 to 2011”, JAMA Internal Medicine, August 12, 2013
150 daysMedian days of testosterone therapy in the 12 months after a first prescription, for men who began in 2010Baillargeon J. et al., “Trends in androgen prescribing in the United States, 2001 to 2011”, JAMA Internal Medicine, August 12, 2013
18.63%Men starting testosterone in 2010 who filled a single prescription, at most 30 days of therapy, and no second oneBaillargeon J. et al., “Trends in androgen prescribing in the United States, 2001 to 2011”, JAMA Internal Medicine, August 12, 2013

Baillargeon’s figures come from a US commercial insurance database of at least 1.27 million men 40 or older in each year studied.

Trial evidence

What the large testosterone trials found, in their own populations

Three results from randomized, placebo-controlled trials, each stated for the men the trial enrolled.

FigureWhat it measuresSource
7.0% vs 7.3%Major adverse cardiac events on testosterone gel against placebo in TRAVERSE, 5,246 men aged 45 to 80 with hypogonadism and cardiovascular riskLincoff A.M. et al., “Cardiovascular Safety of Testosterone-Replacement Therapy”, NEJM, July 13, 2023
3.50% vs 2.46%Clinical fractures on testosterone against placebo in TRAVERSE over a median follow-up of 3.19 yearsSnyder P.J. et al., “Testosterone Treatment and Fractures in Men with Hypogonadism”, NEJM, January 18, 2024
20.5% vs 12.6%Men 65 or older in the Testosterone Trials who walked at least 50 meters farther in six minutes, on testosterone against placebo; vitality did not improveSnyder P.J. et al., “Effects of Testosterone Treatment in Older Men”, NEJM, February 18, 2016

TRAVERSE also recorded more atrial fibrillation, acute kidney injury and pulmonary embolism in the testosterone group.

Rules and enforcement

The dates and dollar amounts behind the rules

A DEA deadline, an FDA labeling change and an FTC order that set what a TRT clinic’s pages may say.

FigureWhat it measuresSource
December 31, 2026The date the DEA flexibility runs through: until then a registered practitioner may prescribe Schedule II to V drugs, testosterone included, by telemedicine without an in-person evaluationDEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities, 90 FR 61301, December 31, 2025
February 28, 2025Date FDA ordered every testosterone label to add the TRAVERSE results and a blood pressure warning and to drop the boxed cardiovascular warningFDA statement on class-wide testosterone labeling, February 28, 2025
$150,000Amount the FTC’s final order required of telehealth firm NextMed, approved December 3, 2025 and expected to fund refunds to consumersFederal Trade Commission, final order against NextMed, December 3, 2025

No fifth extension and no final special-registration rule had appeared in the Federal Register by November 9, 2026.

Costs

Visit, lab and certification costs, at public rates

Medicare’s national rates are the public benchmark for what a visit or a lab panel is worth; a cash-pay clinic sets its own prices.

FigureWhat it measuresSource
$177.36Medicare’s 2026 national amount for a moderate first office visit (CPT 99204), non-facility, before geographic adjustment; $135.61 for a moderate return visit (CPT 99214)CMS, Physician Fee Schedule Relative Value File RVU26D, August 26, 2026 (our arithmetic on 5.31 and 4.06 RVUs at $33.4009)
$25.81Medicare’s 2026 national rate for a total testosterone test (CPT 84403); the unbound testosterone test (CPT 84402) is $25.47CMS, Clinical Laboratory Fee Schedule, 2026 fourth-quarter file (26CLABQ4)
$105.38Total and unbound testosterone, estradiol, PSA and a complete blood count together, at Medicare’s 2026 national lab ratesCMS, Clinical Laboratory Fee Schedule, 2026 fourth-quarter file (26CLABQ4); our sum of CPT 84403, 84402, 82670, 84153 and 85025
$3,125First-year cost of LegitScript healthcare certification for one root domain, a $975 application fee plus a $2,150 annual fee; Google requires it only of telemedicine providers and addiction servicesLegitScript, Healthcare Merchant Certification and its FAQ, no date shown; Google Ads, Healthcare and medicines policy, read November 12, 2026

Medicare’s amounts include the patient’s share. LegitScript charges $2,500 more for expedited processing, and the annual fee is due only once an application is approved.

Search demand

What men search, and what Google shows them

Semrush’s US data for testosterone and TRT clinic searches, with the share of volume that shows an AI Overview, a local pack or no click price.

FigureWhat it measuresSource
40,500US searches a month for “testosterone replacement therapy”, in a family of 8,071 searches totaling 121,950Semrush US database, Keyword Magic Tool, seed “testosterone replacement therapy”, October 10, 2026
12,100Monthly US searches for “trt clinic near me”, the largest phrase in the 55,410-search “trt clinic” familySemrush US database, Keyword Magic Tool, seed “trt clinic”, October 10, 2026
14,800US searches a month for “what is trt”, the most-searched TRT questionSemrush US database, Keyword Magic Tool questions, seed “trt”, October 10, 2026
2,900US searches a month for each of “how much does trt cost” and “is trt safe”Semrush US database, Keyword Magic Tool questions, seed “trt”, October 10, 2026
1,300US searches a month for “is trt covered by insurance”, plus 720 for “does insurance cover trt”Semrush US database, Keyword Magic Tool questions, seed “trt”, October 10, 2026
59.0%Share of the 150,970 monthly TRT question searches whose results show a Google AI OverviewSemrush US database, questions for seed “trt” (October 10, 2026); Webzenia’s sum of AI Overview volume
53.6%Share of the “trt clinic” family’s monthly volume whose results show a Google local packSemrush US database, seed “trt clinic” (October 10, 2026); Webzenia’s sum of local pack volume
18.4%Share of the 55,410 monthly “trt clinic” searches that say online, telehealth or virtualSemrush US database, Keyword Magic Tool, seed “trt clinic”, October 10, 2026; Webzenia analysis
77.4%Share of the “trt clinic” family’s monthly volume with no recorded cost per clickSemrush US database, Keyword Magic Tool, seed “trt clinic”, October 10, 2026; Webzenia analysis
140The most US searches a month for any owner-side men’s health or TRT marketing phrase, reached by “trt seo” and “hrt marketing”Semrush US database, Keyword Magic Tool and organic positions exports, men’s health and hormone clinic seeds, October 10, 2026

Volumes are Semrush’s monthly US estimates. The shares are Webzenia’s sums over the rows Semrush exported.

How the figures were chosen

What we counted as a source

A figure appears here only after we read it in the study, rule or dataset that first published it. What passed, and what did not:

Included

  • Peer-reviewed studies read on PubMed or PMC, with the population each one enrolled
  • Federal rules and orders from DEA, FDA, the FTC and CMS, each with its date
  • Semrush for its own US search data, dated and attributed to Semrush
  • LegitScript’s own fee schedule for its certification

Left out

  • TRT market-size estimates that differ nearly fourfold
  • Counts of US men’s health clinics with no primary source
  • Vendor claims about calls, reviews or agency fees
  • Guideline text we could not read past a login

Questions

What these figures can and cannot tell a clinic

Short answers, each tied to a source above.

Start here

Compare these figures with your clinic’s own starts and retention

Tell us the metros you serve. We send a dated sheet of the questions men put to AI engines there, and which clinics each answer names.